In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab. Leukemia 2020 Jan;34(1):317-321
Date
08/15/2019Pubmed ID
31409922DOI
10.1038/s41375-019-0536-3Scopus ID
2-s2.0-85070798814 (requires institutional sign-in at Scopus site) 30 CitationsAuthor List
Atanackovic D, Yousef S, Shorter C, Tantravahi SK, Steinbach M, Iglesias F, Sborov D, Radhakrishnan SV, Chiron M, Miles R, Salama M, Kröger N, Luetkens TAuthor
Sabarinath Venniyil Radhakrishnan MD Assistant Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Antibodies, MonoclonalAntibodies, Monoclonal, Humanized
Antibodies, Neoplasm
Antigens, Neoplasm
Antineoplastic Agents, Immunological
Humans
Membrane Proteins
Multiple Myeloma
Pilot Projects
